These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8185168

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Proglumide has access to brain and antagonizes the central satiety effect of cholecystokinin octapeptide in the dog.
    Inui A, Inoue T, Sakatani N, Oya M, Morioka H, Baba S.
    Brain Res; 1987 Aug 11; 417(2):355-9. PubMed ID: 3651819
    [Abstract] [Full Text] [Related]

  • 3. Satiating effect of cholecystokinin.
    Smith GP, Gibbs J.
    Ann N Y Acad Sci; 1994 Mar 23; 713():236-41. PubMed ID: 8185165
    [No Abstract] [Full Text] [Related]

  • 4. Bombesin-like peptides and satiety.
    Gibbs J, Guss JL.
    Appetite; 1995 Jun 23; 24(3):257. PubMed ID: 7574572
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans.
    Drewe J, Gadient A, Rovati LC, Beglinger C.
    Gastroenterology; 1992 May 23; 102(5):1654-9. PubMed ID: 1568575
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women.
    Lieverse RJ, Masclee AA, Jansen JB, Rovati LC, Lamers CB.
    Biol Psychiatry; 1995 Mar 01; 37(5):331-5. PubMed ID: 7748985
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of satiety by a cholecystokinin antagonist is independent of gastric emptying.
    Collins SM, Weingarten HP.
    Peptides; 1984 Mar 01; 5(3):481-4. PubMed ID: 6089141
    [Abstract] [Full Text] [Related]

  • 14. Endogenous CCK and the peripheral neural substrates of intestinal satiety.
    Ritter RC, Brenner LA, Tamura CS.
    Ann N Y Acad Sci; 1994 Mar 23; 713():255-67. PubMed ID: 8185167
    [No Abstract] [Full Text] [Related]

  • 15. Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans.
    Gutzwiller JP, Drewe J, Ketterer S, Hildebrand P, Krautheim A, Beglinger C.
    Am J Physiol Regul Integr Comp Physiol; 2000 Jul 23; 279(1):R189-95. PubMed ID: 10896881
    [Abstract] [Full Text] [Related]

  • 16. Gut hormone hypothesis of postprandial satiety.
    Smith GP.
    Res Publ Assoc Res Nerv Ment Dis; 1984 Jul 23; 62():67-75. PubMed ID: 6320318
    [No Abstract] [Full Text] [Related]

  • 17. Cholecystokinin and satiety: current perspectives.
    Moran TH.
    Nutrition; 2000 Oct 23; 16(10):858-65. PubMed ID: 11054590
    [Abstract] [Full Text] [Related]

  • 18. Pregastric stimulation and cholecystokinin are not sufficient for the meal size-intermeal interval correlation in the rat.
    Kraly FS.
    Physiol Behav; 1981 Sep 23; 27(3):457-62. PubMed ID: 7335786
    [No Abstract] [Full Text] [Related]

  • 19. Role of CCK in satiety and appetite control.
    Smith GP, Gibbs J.
    Clin Neuropharmacol; 1992 Sep 23; 15 Suppl 1 Pt A():476A. PubMed ID: 1498917
    [No Abstract] [Full Text] [Related]

  • 20. Cholecystokinin and control of food intake.
    Reidelberger RD.
    J Nutr; 1994 Aug 23; 124(8 Suppl):1327S-1333S. PubMed ID: 8064379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.